Previous close | 151.18 |
Open | 152.04 |
Bid | 149.60 x 1100 |
Ask | 150.00 x 900 |
Day's range | 149.14 - 152.33 |
52-week range | 143.13 - 175.97 |
Volume | |
Avg. volume | 7,746,778 |
Market cap | 360.809B |
Beta (5Y monthly) | 0.53 |
PE ratio (TTM) | 22.28 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 4.96 (3.28%) |
Ex-dividend date | 20 May 2024 |
1y target est | N/A |
NEW BRUNSWICK, N.J., May 01, 2024--Johnson & Johnson (NYSE: JNJ) (the "Company") today announced a proposed Plan of Reorganization (the "Plan") by its subsidiary, LLT Management LLC ("LLT"), for the comprehensive and final resolution of all current and future claims related to ovarian cancer arising from cosmetic talc litigation against it and its affiliates in the United States.
NEW BRUNSWICK, N.J., April 16, 2024--In the section titled "Full-Year 2024 Guidance", in the table, row titled "Operational Sales2,5/ Mid-point", the numbers for the April 2024 column should read: $88.7B – $89.1B / $88.9B (instead of: $88.7B – $89.1B / $88.0B).
NEW BRUNSWICK, N.J., April 16, 2024--Johnson & Johnson (NYSE: JNJ) today announced that its Board of Directors has declared a 4.2% increase in the quarterly dividend, from $1.19 per share to $1.24 per share, marking the 62nd year of consecutive increases.